Clinical Trial Update: Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity [Phase 1]

View source ↗

Summary

Phase 1 study updates ABBV-950 injections in adults with upper limb spasticity, focusing on adverse events and changes in disease activity; the trial has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Limb Spasticity

Drugs mentioned

• ABBV-950

Snippet

Sponsor: AbbVie | Conditions: Upper Limb Spasticity | Phase 1 | Status: TERMINATED